Abstract
Atheromatous renovascular disease (ARVD) is a common and challenging disease. It is increasingly associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), hypertension and cardiovascular burden. Controversy exists regarding the safest investigative methods as well as optimum treatment of this condition. In this review, we provide an overview of ARVD and discuss the challenges still remaining. © 2008 European Dialysis and Transplant Nurses Association/European Renal Care Association.
| Original language | English |
|---|---|
| Pages (from-to) | 179-190 |
| Number of pages | 11 |
| Journal | Journal of Renal Care |
| Volume | 34 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Dec 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Angioplasty and stent for renal arterial lesions (ASTRAL)
- Angiotensin converting enzyme-inhibitors (ACE-I)
- Angiotensin receptor blockers (ARB)
- Atheromatous renovascular disease
- Atherosclerosis
- CKDHypertension
Fingerprint
Dive into the research topics of 'Atheromatous renovascular disease: Overview and challenges'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver